U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K [] Form 20-F [] Form 11-K [] Form 10-Q [] Form N-SAR
For Period Ended: SEPTEMBER 30, 1996
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Report ended: ________________________
----------------------------------------------------------------------
Read Attached Instruction Sheet Before Preparing Form. Please Print
or Type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION
HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
----------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
______________________________________________________________________
PART I - REGISTRANT INFORMATION
______________________________________________________________________
Full Name of Registrant
Former Name if Applicable ADVANCED NMR SYSTEMS,
INC.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Address of Principal Executive Office
(Street and Number) 46 JONSPIN ROAD
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
City, State and Zip Code Wilmington, MA 01887
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
______________________________________________________________________
PART II - RULES 12B-25 (B) AND (C)
______________________________________________________________________
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without reasonable effort or
expense;
[X]
(b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or
portion thereof will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25 has been attached if applicable.
<PAGE>
______________________________________________________________________
PART III - NARRATIVE
______________________________________________________________________
State below in reasonable detail the reasons why the Form 10-K, 11-K,
10-Q, N-SAR, or the transition report or portion thereof, could not be
filed within the prescribed time period. (Attach Extra Sheets if
Needed)
OUR AUDITORS REQUIRED ADDITIONAL TIME TO COMPLETE THE ADVANCED
NMR SYSTEMS, INC. FINANCIAL STATEMENTS.
______________________________________________________________________
PART IV - OTHER INFORMATION
______________________________________________________________________
(1) Name and telephone number of person to contact in regard to
this notification
Stephen R. Jenney (508) 658-5357
--------------------- -----------------------
(Name) (Area Code)(Telephone Number)
(2) Have all other Periodic reports required under section 13 or
15(d) of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for
such shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify reports(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will
be reflected by the earnings statements to be included in the subject
report or portion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Advanced NMR Systems, Inc.
--------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date December 30, 1996 By /s/ Charles Moche
----------------- -----------------------------
Charles Moche, Chief Financial Officer
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name
and title of the person signing the form shall be typed or printed
beneath the signature. If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive
officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
______________________________________________________________________
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
______________________________________________________________________
<PAGE>
______________________________________________________________________
PART IV - OTHER INFORMATION - (CONTINUED)
______________________________________________________________________
Statement regarding (3):
On August 6, 1996, Advanced NMR Systems, Inc. ("ANMR" or the
"Company") announced the elimination of research, development and
production of certain imaging systems technologies. In connection
with this announcement, ANMR expects to incur a one-time charge
totaling approximately $4,100,000 for the year ended September 30,
1996.
During fiscal 1996, the Company switched from consolidation of its
Advanced Mammography Systems, Inc. ("AMS") subdisiary to the equity
method of accounting. This change resulted from the conversion of AMS
debentures into 1,748,364 shares of Common Stock. The Company
currently owns approximately 48% of the outstanding AMS Common Stock.